Ticker
ENTXCompany Name
ENTERA BIO LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 19.67M | $ 18.87M | $ 794K | $ 0 |
3/31/2025 | $ 21.6M | $ 20.57M | $ 1.03M | $ 0 |
12/31/2024 | $ 9.39M | $ 8.66M | $ 730K | $ 0 |
9/30/2024 | $ 7.74M | $ 6.92M | $ 826K | $ 0 |
6/30/2024 | $ 10.04M | $ 9.06M | $ 979K | $ 0 |
3/31/2024 | $ 10.24M | $ 9.19M | $ 1.05M | $ 0 |
12/31/2023 | $ 11.77M | $ 11.02M | $ 746K | $ 0 |
9/30/2023 | $ 8.56M | $ 7.58M | $ 980K | $ 0 |
6/30/2023 | $ 10.45M | $ 9.13M | $ 1.31M | $ 0 |
3/31/2023 | $ 11.61M | $ 10.69M | $ 915K | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ENTERA BIO LTD is calculated as follows: Assets [ $ 8.78M ] - Intangibles [ $ 605K ] - CashnEq [ $ 7.07M ]
(=) Core Assets [ $ 1.11M ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 805.95M |
median | $ 292.02M |
std | $ 1.06B |